A STUDY involving 139,695 patients undergoing balloon-expandable valve (BEV) transcatheter aortic valve replacement (TAVR), has demonstrated that patients younger than 65 years exhibit a higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback